We are live on ! Find out more
AXLA

Axcella Health Inc. Common Stock
AXLA

Delisted

AXLA was delisted on the 22nd of November, 2023.

Back to rankings

28 hedge funds and large institutions have $10.5M invested in Axcella Health Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 9 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 29 → 28 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

56% less capital invested

Capital invested by funds: $23.6M → $10.5M (-$13.1M)

89% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 9

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1K

Holders
28
Holders Change
-1
Holders Change %
-3.45%
% of All Funds
0.44%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
1
Reduced
9
Closed
4
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
+$1K

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$9.42K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.9K
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$216

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$285K
2
CCM
CAAS Capital Management
New York
-$54.3K
3
ZIM
Zacks Investment Management
Illinois
-$50K
4
BlackRock
BlackRock
New York
-$19.3K
5
Millennium Management
Millennium Management
New York
-$17.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$6.39M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$2.24M -$285K -30,426 -7%
HP
3
Harbourvest Partners
Massachusetts
$1.36M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$180K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$73.9K – – –
BlackRock
6
BlackRock
New York
$54.1K -$19.3K -2,060 -17%
BCM
7
Bridgeway Capital Management
Texas
$43.7K – – –
Edgewood Management
8
Edgewood Management
Connecticut
$21.8K – – –
State Street
9
State Street
Massachusetts
$16.9K – – –
Millennium Management
10
Millennium Management
New York
$15.8K -$17.7K -1,887 -39%
Northern Trust
11
Northern Trust
Illinois
$11.2K – – –
Thrivent Financial for Lutherans
12
Thrivent Financial for Lutherans
Minnesota
$11K – – –
VF
13
Virtu Financial
New York
$10K -$14.5K -1,549 -46%
Bank of New York Mellon
14
Bank of New York Mellon
New York
$9.51K – – –
CCM
15
CAAS Capital Management
New York
$8.14K -$54.3K -5,788 -80%
TRCT
16
Tower Research Capital (TRC)
New York
$7.15K +$4.9K +522 +66%
Morgan Stanley
17
Morgan Stanley
New York
$5.48K +$9.42K +1,004 New
Charles Schwab
18
Charles Schwab
California
$3.98K – – –
Bank of America
19
Bank of America
North Carolina
$3.58K – – –
Renaissance Technologies
20
Renaissance Technologies
New York
$3K -$3.49K -372 -42%
TC
21
TownSquare Capital
Utah
$2.61K – – –
PWG
22
Portside Wealth Group
Utah
$2.61K +$4.48K +478 New
LC
23
Lindbrook Capital
California
$437 – – –
UBS Group
24
UBS Group
Switzerland
$196 -$2K -213 -86%
Group One Trading
25
Group One Trading
Illinois
$87 – – –
1
2

AXLA Hedge Fund Activity: Q2 2023 in Review

28 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2023, worth a combined $10.5M — down 56% from $23.6M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of AXLA and 3 opened new positions — a net loss of 1 holder — while 9 trimmed existing stakes and 1 added.

The largest buyer was Morgan Stanley, opening a new position worth an estimated $9.42K. The largest seller was Fidelity Investments, cutting an estimated $285K.

  • 28 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2023, down from 29 in Q1 2023.
  • Funds reported $10.5M of Axcella Health Inc. Common Stock stock for Q2 2023, down 56% quarter-over-quarter.
  • 3 funds opened new Axcella Health Inc. Common Stock positions in Q2 2023 and 4 closed out, a net change of -1 holder.
  • The largest Axcella Health Inc. Common Stock buyer in Q2 2023 was Morgan Stanley, an estimated $9.42K added.
  • The largest Axcella Health Inc. Common Stock seller in Q2 2023 was Fidelity Investments, an estimated $285K sold.

Based on aggregated 13F filings for Q2 2023.